David Singer
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
Sector and stage focus
- Seed: Pharmaceuticals, Therapeutics, Digital Health
- Series A: Pharmaceuticals, Therapeutics, Digital Health
- general: San Francisco Bay Area
Recent investments by David Singer
David Singer has 8 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Science Exchange | Series Unknown | Oct 2019 | $20M |
| Collective Health | Series F | May 2021 | $280M |
| Volta Labs | Series A | Mar 2022 | $20M |
| Spear Bio | Series A | Jul 2024 | $45M |
| Seer | Series D | Jul 2020 | $55M |
| Nodality | Series Unknown | Jul 2012 | $15M |
| Oula Health | Series B | Feb 2024 | $28M |
| Ambrx | Series D | Apr 2009 | $10M |
Frequent co-investors
David Singer has co-invested with: Mohamad Makhzoumi, Blake Byers, Bobby Yazdani, Lee Linden, Kal Vepuri, Steve Case.
Is David Singer a fit for your round?
Upload your pitch deck and see whether David Singer appears in your top 20 matches.
Find investors for your deck